Company Analysis

Oragenics Inc. (OGEN)

NYSE: OGEN · Pharmaceutical Preparations · Lakewood Ranch, FL · filing with the SEC since 2002
Grade3.5
◀ Past 1.9● Present 3.0▶ Future 4.9
3 est.

Who runs Oragenics Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Huffman Janet
CEO and CFO. First filing Mar 2023, latest Dec 15, 2025, 0 filings in all.
Officers reporting now
2
of 8 people with a filing in the last fifteen months
Directors reporting now
6
15 people on the record since 2009
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Spencer JohnChief Financial OfficerJul 2026Jul 7, 2026none
Huffman JanetCEO and CFOMar 2023Dec 15, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Telling FreddirectorJun 2010Jan 22, 20262 · $0.00
Dunton Alan WdirectorApr 2011Dec 15, 2025none
Gandolfo John PdirectorOct 2023Dec 15, 2025none
Giordano NatashadirectorSep 2025Dec 15, 2025none
Koski Robert CdirectorJul 2009Dec 15, 2025none
Pope Charles LdirectorJun 2010Dec 15, 2025none
Earlier names on the record13, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton OGEN · research, not advice